<?xml version="1.0" encoding="utf-8" standalone="yes"?>
<rss version="2.0" xmlns:atom="http://www.w3.org/2005/Atom" xmlns:content="http://purl.org/rss/1.0/modules/content/">
  <channel>
    <title>Market-Access on Cognaptus</title>
    <link>https://cognaptus.com/tags/market-access/</link>
    <description>Recent content in Market-Access on Cognaptus</description>
    <generator>Hugo -- 0.145.0</generator>
    <language>en-us</language>
    <lastBuildDate>Mon, 25 Aug 2025 00:00:00 +0000</lastBuildDate>
    <atom:link href="https://cognaptus.com/tags/market-access/index.xml" rel="self" type="application/rss+xml" />
    <item>
      <title>MoA vs. Moat: Agentic LLMs for Drug Competitor Mapping Cut Diligence Time 20×</title>
      <link>https://cognaptus.com/blog/2025-08-25-moa-vs-moat-agentic-llms-for-drug-competitor-mapping-cut-diligence-time-20/</link>
      <pubDate>Mon, 25 Aug 2025 00:00:00 +0000</pubDate>
      <guid>https://cognaptus.com/blog/2025-08-25-moa-vs-moat-agentic-llms-for-drug-competitor-mapping-cut-diligence-time-20/</guid>
      <description>A mechanism-first look at how scaffolded web agents and conservative validation turn messy biotech diligence into faster, more measurable competitor mapping.</description>
    </item>
  </channel>
</rss>
